HSBC Holdings’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $70.6M | Sell |
119,235
-24,389
| -17% | -$12.1M | 0.04% | 416 |
|
|
2025
Q4 | $70.1M | Sell |
143,624
-12,743
| -8% | -$5.93M | 0.04% | 411 |
|
|
2025
Q3 | $65.6M | Sell |
156,367
-28,427
| -15% | -$9.56M | 0.04% | 422 |
|
|
2025
Q2 | $53.1M | Buy |
184,794
+5,088
| +3% | +$1.52M | 0.03% | 467 |
|
|
2025
Q1 | $55.4M | Sell |
179,706
-25,187
| -12% | -$8.63M | 0.03% | 458 |
|
|
2024
Q4 | $72.4M | Sell |
204,893
-20,349
| -9% | -$7.48M | 0.04% | 392 |
|
|
2024
Q3 | $80.7M | Buy |
225,242
+162,381
| +258% | +$54.9M | 0.05% | 370 |
|
|
2024
Q2 | $20M | Sell |
62,861
-53,897
| -46% | -$14.3M | 0.01% | 679 |
|
|
2024
Q1 | $26.8M | Buy |
116,758
+22,065
| +23% | +$4.98M | 0.02% | 619 |
|
|
2023
Q4 | $20.8M | Buy |
94,693
+5,416
| +6% | +$1.25M | 0.02% | 658 |
|
|
2023
Q3 | $20.2M | Buy |
89,277
+1,635
| +2% | +$377K | 0.02% | 625 |
|
|
2023
Q2 | $19.4M | Buy |
87,642
+21,995
| +34% | +$4.87M | 0.02% | 633 |
|
|
2023
Q1 | $14.7M | Buy |
65,647
+54,065
| +467% | +$13.3M | 0.02% | 706 |
|
|
2022
Q4 | $3.2M | Buy |
11,582
+5,507
| +91% | +$1.39M | ﹤0.01% | 1484 |
|
|
2022
Q3 | $1.27M | Sell |
6,075
-304
| -5% | -$68K | ﹤0.01% | 1729 |
|
|
2022
Q2 | $1.51M | Buy |
6,379
+1,907
| +43% | +$388K | ﹤0.01% | 1722 |
|
|
2022
Q1 | $801K | Sell |
4,472
-3,708
| -45% | -$706K | ﹤0.01% | 2099 |
|
|
2021
Q4 | $1.77M | Sell |
8,180
-59,433
| -88% | -$11.7M | ﹤0.01% | 1750 |
|
|
2021
Q3 | $12.6M | Buy |
67,613
+58,857
| +672% | +$11.6M | 0.01% | 794 |
|
|
2021
Q2 | $1.57M | Buy |
+8,756
| New | +$1.67M | ﹤0.01% | 1537 |
|
|
2021
Q1 | – | Sell |
-7,713
| Closed | -$1.16M | – | 3150 |
|
|
2020
Q4 | $1.16M | Sell |
7,713
-1,842
| -19% | -$242K | ﹤0.01% | 1602 |
|
|
2020
Q3 | $970K | Sell |
9,555
-438
| -4% | -$48.1K | ﹤0.01% | 1560 |
|
|
2020
Q2 | $1.21M | Sell |
9,993
-3,957
| -28% | -$445K | ﹤0.01% | 1362 |
|
|
2020
Q1 | $1.32M | Sell |
13,950
-5,467
| -28% | -$520K | ﹤0.01% | 1357 |
|
|
2019
Q4 | $1.71M | Sell |
19,417
-2,491
| -11% | -$219K | ﹤0.01% | 1561 |
|
|
2019
Q3 | $1.75M | Sell |
21,908
-66,644
| -75% | -$5.37M | ﹤0.01% | 1666 |
|
|
2019
Q2 | $6.91M | Buy |
88,552
+31,432
| +55% | +$2.94M | 0.01% | 1010 |
|
|
2019
Q1 | $6.7M | Buy |
57,120
+13,873
| +32% | +$1.62M | 0.01% | 1000 |
|
|
2018
Q4 | $4.71M | Sell |
43,247
-4,316
| -9% | -$500K | 0.01% | 1129 |
|
|
2018
Q3 | $6.08M | Sell |
47,563
-4,980
| -9% | -$616K | 0.01% | 1046 |
|
|
2018
Q2 | $5.94M | Sell |
52,543
-4,379
| -8% | -$481K | 0.01% | 1040 |
|
|
2018
Q1 | $6.4M | Sell |
56,922
-6,141
| -10% | -$780K | 0.01% | 1018 |
|
|
2017
Q4 | $9.32M | Buy |
63,063
+9,904
| +19% | +$1.26M | 0.01% | 695 |
|
|
2017
Q3 | $6.22M | Sell |
53,159
-20,825
| -28% | -$2.66M | 0.01% | 966 |
|
|
2017
Q2 | $9.6M | Buy |
73,984
+7,303
| +11% | +$911K | 0.02% | 774 |
|
|
2017
Q1 | $9.19M | Buy |
66,681
+418
| +0.6% | +$63.3K | 0.02% | 756 |
|
|
2016
Q4 | $9.5M | Sell |
66,263
-7,017
| -10% | -$896K | 0.02% | 743 |
|
|
2016
Q3 | $8.65M | Sell |
73,280
-32,141
| -30% | -$3.86M | 0.02% | 725 |
|
|
2016
Q2 | $11.2M | Buy |
105,421
+34,040
| +48% | +$3.8M | 0.03% | 617 |
|
|
2016
Q1 | $7.95M | Buy |
71,381
+35,734
| +100% | +$4.52M | 0.02% | 728 |
|
|
2015
Q4 | $5.58M | Sell |
35,647
-8,913
| -20% | -$1.3M | 0.01% | 898 |
|
|
2015
Q3 | $5.85M | Buy |
44,560
+15,429
| +53% | +$2.47M | 0.01% | 763 |
|
|
2015
Q2 | $5.07M | Buy |
29,131
+16,786
| +136% | +$3.02M | 0.01% | 816 |
|
|
2015
Q1 | $2.13M | Sell |
12,345
-24,791
| -67% | -$3.78M | ﹤0.01% | 1163 |
|
|
2014
Q4 | $4.81M | Sell |
37,136
-1,486
| -4% | -$191K | 0.01% | 912 |
|
|
2014
Q3 | $4.97M | Sell |
38,622
-57,676
| -60% | -$5.95M | 0.01% | 874 |
|
|
2014
Q2 | $8.52M | Buy |
96,298
+4,990
| +5% | +$480K | 0.02% | 682 |
|
|
2014
Q1 | $8.59M | Buy |
91,308
+31,790
| +53% | +$3.25M | 0.02% | 624 |
|
|
2013
Q4 | $6.73M | Sell |
59,518
-68,768
| -54% | -$6.2M | 0.02% | 768 |
|
|
2013
Q3 | $10.1M | Sell |
128,286
-47,746
| -27% | -$3.49M | 0.03% | 595 |
|
|
2013
Q2 | $11.6M | Buy |
+176,032
| New | +$11.3M | 0.03% | 467 |
|
Other funds holding UTHR
ACA
VPM
VCM
HSBC Holdings's UTHR Position: Q1 2026 in Review
HSBC Holdings reduced its United Therapeutics (UTHR) stake by 17% in Q1 2026, selling an estimated $12.1M and leaving 119,235 shares worth $70.6M. The position accounts for 0.04% of the portfolio, ranked #416.
HSBC Holdings first reported a position in UTHR in Q2 2013 and has held it in 51 quarters since. The position peaked at $80.7M in Q3 2024. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- HSBC Holdings held 119,235 shares of United Therapeutics worth $70.6M as of Q1 2026.
- HSBC Holdings sold 24,389 United Therapeutics shares in Q1 2026, an estimated $12.1M.
- United Therapeutics made up 0.04% of HSBC Holdings's portfolio in Q1 2026, its #416 holding.
- HSBC Holdings first reported a position in United Therapeutics in Q2 2013 and has held it in 51 quarters since.
- HSBC Holdings's United Therapeutics position peaked at $80.7M in Q3 2024.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.